在患有抑郁症的患者中维持电治疗的长期影响 - 来自一项小型随机对照试验的数据
Ole Brus1, Yang Cao1, Andreas Carlborg2
1From the Clinical epidemiology and biostatistics, Faculty of Medicine and Health, Örebro University, Örebro.
The journal of ECT
|January 17, 2024
概括
使用药物进行维持性电疗法 (M-ECT) 似乎可以长期维持抑郁症复发的好处. 然而,小样本大小限制了确定性,需要对M-ECT疗效进行进一步研究.
科学领域:
- 精神病学是一个精神病学.
- 神经学 神经学
- 临床试验 临床试验
背景情况:
- 尽管有治疗方法,抑郁症复发仍然是一个重大挑战.
- 维持性电疗法 (M-ECT) 在预防抑郁症发作方面已经显示出短期的有效性.
- 对M-ECT与仅用药的长期比较数据有限.
研究的目的:
- 在患有抑郁症的患者中,比较维持电治疗 (M-ECT) 加药与单独药物的长期影响.
- 评估初始M-ECT治疗后在延长的随访期内复发和复发率.
主要方法:
- 一个随机对照试验,最初比较1年的M-ECT与药物治疗与仅药物治疗.
- 在M-ECT停止后,使用瑞典国家登记处进行长期跟踪 (长达10年).
- 卡普兰-梅尔估计用于比较群体之间的复发时间.
主要成果:
- M-ECT加药组的中位数随访时间为6.5年,仅服用药物组的中位数为3.1年.
- 在视觉检查中,M-ECT完成后的复发模式在各组之间看起来相似.
- 最初的1年结果显示,M-ECT与药物治疗具有显著的优势.
结论:
- 在停止治疗后,M-ECT对抑郁症的长期益处可能会持续.
- 该研究的小样本规模和统计不准确性限制了最终的结论.
- 需要进一步的长期研究来证实M-ECT的持续疗效.
相关概念视频
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Antidepressant Drugs: MAOIs and Other Agents
237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237


